For: | Gato S, Lucena-Valera A, Muñoz-Hernández R, Sousa JM, Romero-Gómez M, Ampuero J. Impact of COVID-19 on liver disease: From the experimental to the clinic perspective. World J Virol 2021; 10(6): 301-311 [PMID: 34909404 DOI: 10.5501/wjv.v10.i6.301] |
---|---|
URL: | https://www.wjgnet.com/2220-3249/full/v10/i6/301.htm |
Number | Citing Articles |
1 |
Juan Carlos Restrepo-Gutiérrez, Ana Isabel Toro-Montoya. Enfermedad hepatobiliar asociada a COVID-19. Hepatología 2022; : 143 doi: 10.52784/27112330.155
|
2 |
Agata Michalak, Tomasz Lach, Karolina Szczygieł, Halina Cichoż-Lach. COVID-19, Possible Hepatic Pathways and Alcohol Abuse—What Do We Know up to 2023?. International Journal of Molecular Sciences 2024; 25(4): 2212 doi: 10.3390/ijms25042212
|
3 |
Ana Pereira, Diana Lima, Mariana Martins, Teresa Plancha-Silva, Marta Amaral-Silva, Elsa Marques. Idiopathic Scoliosis Trends One Year After COVID-19: A Retrospective Study. Cureus 2022; doi: 10.7759/cureus.32779
|
4 |
Ana Lucena Valera, Rocío Aller dela Fuente, Yolanda Sánchez Torrijos, Manuel Romero Gómez, Javier Ampuero Herrojo. FIB-4 Score as Predictor of COVID-19-related Severity in hospitalized patients. Revista Española de Enfermedades Digestivas 2024; doi: 10.17235/reed.2024.9811/2023
|